The impact of a prolonged ebola outbreak on measles elimination activities in Guinea, Liberia and Sierra Leone, 2014-2015.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2020
Historique:
received: 07 05 2019
accepted: 05 01 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 13 11 2020
Statut: epublish

Résumé

Guinea, Sierra Leone and Liberia have attained significant reduction in measles incidence between 2004 and 2013. The Ebola outbreak in 2014-2015 in West Africa caused significant disruption of the health service delivery in the three worst affected countries. The magnitude of the impact on the immunization program has not been well documented. We reviewed national routine immunization administrative coverage data as well as measles surveillance performance and measles epidemiology in the years before, during and after the EVD outbreak in Guinea, Liberia, Sierra Leone. Both Liberia and Guinea experienced a sharp decline of more than 25% in the monthly number of children vaccinated against measles in 2014 and 2015 as compared to the previous years, while there was no reported decline in Sierra Leone. Guinea and Liberia experienced a decline in measles surveillance activity and performance indicators in 2014 and 2015. During this period, there was an increase in measles incidence and a decline in the mean age of measles cases reported in Liberia and Sierra Leone. Guinea started reporting high measles incidence in 2016. All three countries organized measles supplemental immunization activities by June 2015. Liberia achieved 99% administrative coverage, while Guinea and Sierra Leone attained 90.6% and 97.2% coverage respectively. There were no severe adverse events reported during these mass vaccination activities. The disruptive effect of the Ebola outbreak on immunization services was especially evident in Guinea and Liberia. Our review of the reported administrative vaccination coverage at national level does not show significant decline in measles first dose vaccination coverage in Sierra Leone as compared to other reports. This may be due to inaccuracies in coverage monitoring and data quality problems. The increases in measles transmission and incidence in these three countries can be explained by the rapid accumulation of susceptible children. Despite the organization of mass vaccination activities, measles incidence through 2017 has remained higher than the pre-Ebola period in all three countries. The Ebola outbreak in West Africa significantly affected measles vaccination coverage rates in two of the three worst affected countries, and led to persistent gaps in coverage, along with high measles incidence that was documented until two years after the end of the Ebola outbreak. Liberia and Sierra Leone have demonstrated coverage improvements after the end of the Ebola outbreak.

Identifiants

pubmed: 32373259
doi: 10.11604/pamj.supp.2020.35.1.19059
pii: PAMJ-SUPP-35-1-08
pmc: PMC7196330
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8

Informations de copyright

© Balcha Girma Masresha et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Science. 2015 Mar 13;347(6227):1240-2
pubmed: 25766232
Emerg Infect Dis. 2017 Jun;23(6):1035-1037
pubmed: 28518027
Emerg Infect Dis. 2016 Mar;22(3):433-41
pubmed: 26886846
N Engl J Med. 2016 Aug 11;375(6):587-96
pubmed: 27509108
PLoS Pathog. 2014 Nov 13;10(10):e1004438
pubmed: 25393545
Emerg Infect Dis. 2016 Jun;22(6):1106-8
pubmed: 27191621
J Public Health (Oxf). 2016 Dec 02;38(4):673-678
pubmed: 28158472
Emerg Infect Dis. 2007 Jan;13(1):1-5
pubmed: 17370508
PLoS Curr. 2015 Aug 04;7:
pubmed: 26331094
Expert Rev Anti Infect Ther. 2015;13(11):1299-301
pubmed: 26489536
PLoS Curr. 2014 Dec 19;6:
pubmed: 25685617
Lancet. 2015 Nov 28;386(10009):2204-21
pubmed: 26615326
Lancet Glob Health. 2017 Apr;5(4):e448-e457
pubmed: 28237252

Auteurs

Balcha Girma Masresha (BG)

WHO, Regional Office for Africa, Brazzaville, Congo.

Richard Luce (R)

WHO, Inter-country team for Western Africa, Ouagadougou, Burkina Faso.

Goitom Weldegebriel (G)

WHO, Inter-country team for Eastern and Southern Africa, Harare, Zimbabwe.

Reggis Katsande (R)

WHO, Regional Office for Africa, Brazzaville, Congo.

Alex Gasasira (A)

WHO, Country office for Zimbabwe, Harare, Zimbabwe.

Richard Mihigo (R)

WHO, Regional Office for Africa, Brazzaville, Congo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH